Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology.

Guidelines blood pressure clinical settings diabetes healthy lifestyle lipids nutrition physical activity population prevention primary care psychosocial factors rehabilitation risk assessment risk management smoking stakeholder

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 13 12 2019
medline: 22 12 2020
entrez: 13 12 2019
Statut: ppublish

Résumé

European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint Task Force. Given the amount of new information that has become available since then, components from the task force and experts from the European Association of Preventive Cardiology of the European Society of Cardiology were invited to provide a summary and critical review of the most important new studies and evidence since the latest guidelines were published. The structure of the document follows that of the previous document and has six parts: Introduction (epidemiology and cost effectiveness); Cardiovascular risk; How to intervene at the population level; How to intervene at the individual level; Disease-specific interventions; and Settings: where to intervene? In fact, in keeping with the guidelines, greater emphasis has been put on a population-based approach and on disease-specific interventions, avoiding re-interpretation of information already and previously considered. Finally, the presence of several gaps in the knowledge is highlighted.

Identifiants

pubmed: 31826679
doi: 10.1177/2047487319893035
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-205

Commentaires et corrections

Type : CommentIn

Auteurs

Massimo F Piepoli (MF)

Department of Cardiology, Polichirurgico Hospital G Da Saliceto, Italy.
Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy.

Ana Abreu (A)

Serviço de Cardiologia, Universidade de Lisboa, Portugal.

Christian Albus (C)

Department of Pshychosomatics and Psychotherapy, University of Cologne, Germany.

Marco Ambrosetti (M)

Department of Cardiac Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Institute of Pavia, Italy.

Carlos Brotons (C)

Biomedical Research Institute Sant Pau Research Unit, Sardenya Primary Health Care Center, Spain.

Alberico L Catapano (AL)

Department of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, Italy.

Ugo Corra (U)

Department of Cardiac Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Institute of Veruno, Italy.

Bernard Cosyns (B)

Department of Cardiology, Universitair Ziekenhuis Brussel, Belgium.

Christi Deaton (C)

Department of Public Health and Primary Care, University of Cambridge, UK.

Ian Graham (I)

Cardiovascular Medicine, Trinity College Dublin, Ireland.

Arno Hoes (A)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.

Maja-Lisa Lochen (ML)

Department of Community Medicine, UiT the Artic University of Norway, Norway.

Benedetta Matrone (B)

Department of Cardiology, Polichirurgico Hospital G Da Saliceto, Italy.

Josep Redon (J)

INCLIVA Research Institute, University of Valencia, Spain.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.

Yvo Smulders (Y)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.

Monica Tiberi (M)

Azienda Sanitaria Unica Regionale, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH